Lenalidomide hydrochloride
Lenalidomide hydrochloride
Lenalidomide hydrochloride |
A3547-500 |
ApexBio |
500 mg |
EUR 258 |
Description: IC50 Value: 13 nM [1] Lenalidomideis a derivative of thalidomide introduced in 2004. Lenalidomide (Revlimid, CC-5013) is a TNF-? secretion inhibitor with IC50 of 13 nM. in vitro: Lenalidomide strongly induces IL-2 and sIL-2R production. |
Lenalidomide-C4-NH2 (hydrochloride) |
HY-115446A |
MedChemExpress |
500mg |
EUR 1714 |
Lenalidomide |
L044-100MG |
TOKU-E |
100 mg |
EUR 178 |
Lenalidomide |
L044-25MG |
TOKU-E |
25 mg |
EUR 78 |
Lenalidomide |
20-abx076543 |
Abbexa |
|
|
|
Lenalidomide (CC-5013) |
A4211-100 |
ApexBio |
100 mg |
EUR 189 |
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
A4211-250 |
ApexBio |
250 mg |
EUR 224 |
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
A4211-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 113 |
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
A4211-50 |
ApexBio |
50 mg |
EUR 154 |
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
A4211-500 |
ApexBio |
500 mg |
EUR 258 |
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
Lenalidomide (CC-5013) |
A4211-S |
ApexBio |
Evaluation Sample |
EUR 81 |
Description: Lenalidomide (also known as CC-5013), an oral derivative of thalidomide, is an antineoplastic agent exhibiting antitumor activity through a variety of mechanisms, including immune system activation, angiogenesis inhibition, and direct antineoplastic effects. |
(R,S)-Lenalidomide |
1862-100 |
Biovision |
|
EUR 245 |
Lenalidomide (Ubiquitin ligase inducer) |
SIH-410-10MG |
Stressmarq |
10 mg |
EUR 149 |
|
Description: The substance Lenalidomide is a ubiquitin ligase inducer. It is synthetically produced and has a purity of >98%. The pure substance is powder which is soluble in DMSO (200 mM), Water (<1 mM) and Ethanol (<1 mM).. |
Lenalidomide (Ubiquitin ligase inducer) |
SIH-410-50MG |
Stressmarq |
50 mg |
EUR 317 |
|
Description: The substance Lenalidomide is a ubiquitin ligase inducer. It is synthetically produced and has a purity of >98%. The pure substance is powder which is soluble in DMSO (200 mM), Water (<1 mM) and Ethanol (<1 mM).. |
EZSolution? (R,S)-Lenalidomide |
B1503-10 |
Biovision |
|
EUR 120 |
Icotinib hydrochloride |
I035-10MG |
TOKU-E |
10 mg |
EUR 347 |
Kasugamycin hydrochloride |
K005-10G |
TOKU-E |
10 g |
EUR 276 |
Kasugamycin hydrochloride |
K005-1G |
TOKU-E |
1 g |
EUR 86 |
Kasugamycin hydrochloride |
K005-50G |
TOKU-E |
50 g |
EUR 868 |
Methacycline hydrochloride |
M003-100MG |
TOKU-E |
100 mg |
EUR 139 |
Methacycline hydrochloride |
M003-1G |
TOKU-E |
1 g |
EUR 187 |
Minocycline hydrochloride |
M008-1G |
TOKU-E |
1 g |
EUR 347 |
Minocycline hydrochloride |
M008-500MG |
TOKU-E |
500 mg |
EUR 200 |
Mitoxantrone hydrochloride |
M010-50MG |
TOKU-E |
50 mg |
EUR 129 |
Lomefloxacin hydrochloride |
L005-1G |
TOKU-E |
1 g |
EUR 74 |
Lomefloxacin hydrochloride |
L005-5G |
TOKU-E |
5 g |
EUR 153 |
Daunorubicin hydrochloride |
D001-10MG |
TOKU-E |
10 mg |
EUR 119 |
Daunorubicin hydrochloride |
D001-50MG |
TOKU-E |
50 mg |
EUR 400 |
Difloxacin hydrochloride |
D021-1G |
TOKU-E |
1 g |
EUR 111 |
Difloxacin hydrochloride |
D021-5G |
TOKU-E |
5 g |
EUR 365 |
Demeclocycline hydrochloride |
D032-1G |
TOKU-E |
1 g |
EUR 174 |
Demeclocycline hydrochloride |
D032-250MG |
TOKU-E |
250 mg |
EUR 88 |
Demeclocycline hydrochloride |
D032-5G |
TOKU-E |
5 g |
EUR 539 |
Doxycycline Hydrochloride |
D065-25MG |
TOKU-E |
25mg |
EUR 342 |
Doxycycline Hydrochloride |
D065-5MG |
TOKU-E |
5mg |
EUR 119 |
Dalbavancin Hydrochloride |
D092-10MG |
TOKU-E |
10mg |
EUR 127 |
Dalbavancin Hydrochloride |
D092-50MG |
TOKU-E |
50mg |
EUR 380 |
Dimethylamine hydrochloride |
DB0410 |
Bio Basic |
500g |
EUR 96.98 |
|
Betaine hydrochloride |
BB0133 |
Bio Basic |
250g |
EUR 75.52 |
|
Benzamidine hydrochloride |
BD0076 |
Bio Basic |
25g |
EUR 81.32 |
|
Cefepime Hydrochloride |
C009-100MG |
TOKU-E |
100 mg |
EUR 267 |
Ceftazidime Hydrochloride |
C020-1G |
TOKU-E |
1 g |
EUR 622 |
Ciprofloxacin hydrochloride |
C032-25G |
TOKU-E |
25 g |
EUR 166 |
Lenalidomide hydrochloride